- Previous Close
0.0000 - Open
1.1300 - Bid 0.3500 x 46000
- Ask 0.4621 x 40000
- Day's Range
0.3250 - 1.1300 - 52 Week Range
0.3250 - 46.8000 - Volume
128,418 - Avg. Volume
20,924 - Market Cap (intraday)
1.057M - Beta (5Y Monthly) 1.63
- PE Ratio (TTM)
-- - EPS (TTM)
-40.4000 - Earnings Date Apr 3, 2025 - Apr 7, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.50
Danimer Scientific, Inc., a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company products are used in various applications, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia. On March 18, 2025, Danimer Scientific, Inc. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
www.danimerscientific.com257
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DNMR
View MorePerformance Overview: DNMR
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DNMR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DNMR
View MoreValuation Measures
Market Cap
1.06M
Enterprise Value
391.91M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.03
Price/Book (mrq)
0.00
Enterprise Value/Revenue
10.47
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-297.10%
Return on Assets (ttm)
-7.96%
Return on Equity (ttm)
-43.11%
Revenue (ttm)
37.43M
Net Income Avi to Common (ttm)
-111.2M
Diluted EPS (ttm)
-40.4000
Balance Sheet and Cash Flow
Total Cash (mrq)
22.19M
Total Debt/Equity (mrq)
195.20%
Levered Free Cash Flow (ttm)
-26.48M